Yarrow Bioscience Inc (YARW)

US · Healthcare · Biotechnology

$15.60+14.71%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$97,000

Revenue YoY

+40.6%

Net profit

$-3.0M

EPS

$-2.14

Net margin

-3,100.0%

Market cap

$126.5M

Forward P/E

0.0

P/B

0.00

Book value

$-26.06

52-week high

$44.28

52-week low

$9.65

50-day MA

$24.30

200-day MA

$30.60

Beta

2.13

Analysts rate Yarrow Bioscience Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $57.00.

Insiders

2.02%

Institutions

42.13%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Yarrow Bioscience Inc — free to start.

Data updated 2026-11-07.